a public good project by the
Synthesis
Company
of California

© 2026

Shuichi Miyawaki | doi.page

0 works0 citations0 h-index

Shuichi Miyawaki

Publications by Year

Research Areas

Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, Hematopoietic Stem Cell Transplantation

Most-Cited Works

→ Frequent pathway mutations of splicing machinery in myelodysplasia(2011)2,044 cited
→ Integrated molecular analysis of adult T cell leukemia/lymphoma(2015)830 cited
→ Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.(1999)765 cited
→ High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group(2005)453 cited
→ Dynamics of clonal evolution in myelodysplastic syndromes(2016)417 cited
→ Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms(2013)388 cited
→

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study

(2010)

260 cited

→ Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients(2014)229 cited

→ Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study(2002)188 cited

→ A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study(2010)171 cited